What is JNJ's current stock price?

As of now, JNJ is trading at $194.39, with a daily change of +0.26%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

JNJ Stock Analysis & IQ Rating | Johnson & Johnson

JNJ

Johnson & Johnson

$194.39

+$0.50 | +0.26%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$ 195.55

MKT CAP

$ 468.34B

52W Low

$ 140.68

VOL

$ 5.71M

P/E Ratio

18.76

AVG VOL

$ 8.05M

RSI

66.78

TREND

Uptrend

JNJ Stock IQ

Login to see Johnson & Johnson (JNJ) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

JNJ Target Price

Login to display

Strengths

JNJ Rewards

Earnings are forecast to grow

JNJ Rewards

Upgraded on attractively valued

JNJ Rewards

Investors confidence is positive

JNJ Rewards

Pays a reliable dividend

Chart

$190.9 (+1.83%)

$176.64 (+10.05%)

$150.73 (+28.97%)

$155.5 (+25.01%)

1year

6month

3month

1month

JNJ Risk Level

JNJ has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

JNJ Analysts Opinion

JNJ overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

JNJ Analysts Opinion

JNJ Analysts opinion is negative and it remained unchanged from the past 3 months

JNJ Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

92%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

80%

JNJ Street Sentiment

JNJ Street Sentiment is extremely bullish and have positive views on the near-term outlook

JNJ Performance Sentiment

Sentiments overview associated with JNJ events and the stock performance.

92%

8%

Positive

Negative

33 out of 36
events present

3 out of 36
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$186.97

Resistance
Price

$182.74

Current Price Range

$193.72

Show methods +

Linked to JNJ

IQ

Close Price

Change

NBTX

2.50

21.58

+3.13%

SNDX

3.72

16.79

-5.30%

REGN

4.23

681.72

+1.06%

PFE

3.88

25.84

+1.43%

PCRX

3.59

23.86

-1.08%

JNJ Latest Analysis +

Notable Wednesday Option Activity: AMGN SD JNJ. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Amgen Inc (Symbol: AMGN) where a total volume of 12744 contracts has been traded thus far today a contract volume which is representative of approximately 1.3

Today

$194.39 | +0.26%

Momentum

J&Js MedTech Unit Sales Improve: Will the Momentum Last?. J&Js MedTech sales rose 5.6% in Q3 fueled by cardiovascular strength and strategic portfolio shifts toward high-growth markets.

Today

$194.39 | +0.26%

Activity

Dow Analyst Moves: JNJ. The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average Johnson &. Johnson is the #13 analyst pick. Johnson &. Johnson also comes in above the median of analyst picks among the broader

Tue Nov 11, 2025

$193.83 | +2.98%

Potential

Johnson & Johnson (JNJ) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript.

Tue Nov 11, 2025

$193.83 | +2.98%

Activity

Johnson & Johnson (JNJ) Presents at UBS Global Healthcare Conference 2025 Transcript.

Tue Nov 11, 2025

$193.83 | +2.98%

Activity

Wall Street Analysts See Johnson & Johnson (JNJ) as a Buy: Should You Invest?. The average brokerage recommendation (ABR) for Johnson & Johnson (JNJ) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So is it worth buying the stock?

Tue Nov 11, 2025

$193.83 | +2.98%

Potential

Johnson & Johnson: 2 Recent FDA Wins And Earnings Beat Warrant Buy Rating.

Mon Nov 10, 2025

$188.41 | +0.99%

Earnings

Rating

FDA Clears Johnson & Johnsons Darzalex Faspro Enabling Early Intervention In Myeloma Progression. The United States Food and Drug Administration (FDA) approved on Thursday ) Darzalex Faspro (daratumumab and hyaluronidase-fihj) for a .Darzalex Faspro is the first and only approved treatment for high-risk smoldering multiple myeloma (HR-SMM) enabling earlier intervention before the disease progresses to active multiple myeloma.Smoldering multiple myeloma is an asymptomatic (no signs or symptoms) .

Fri Nov 7, 2025

$186.57 | -0.21%

Activity

Potential

Halozyme JNJ Win FDA Approval For DARZALEX Faspro In High-Risk Smoldering Multiple Myeloma . (RTTNews) - Halozyme Therapeutics Inc. (HALO) Friday announced that Johnson & Johnson has received United States Food and Drug Administration approval of a new indication for DARZALEX Faspro as a single agent treatment of adult patients with high-risk smoldering multiple myeloma.

Fri Nov 7, 2025

$186.57 | -0.21%

Activity

Potential

FDA Approves J&J Caplyta As Add-On Therapy For Major Depressive Disorder In Adults . (RTTNews) - Johnson & Johnson (JNJ) on Thursday announced that the United States Food and Drug Administration (FDA) has approved Caplyta as an add-on therapy with antidepressants for the treatment of major depressive disorder (MDD) in adults.

Thu Nov 6, 2025

$186.97 | +0.51%

Activity

FAQ About JNJ Stock Insights

What is JNJ current stock price?

What are JNJ stock strengths?

What risks are associated with JNJ stock?

When is JNJ next earnings report?

What is JNJ market cap and volume?

What is JNJ's current Stock IQ?

Should I buy JNJ stock right now?

Is JNJ a Strong Buy right now?

What does a 'Strong Buy' rating mean for JNJ?

What does a 'Strong Sell' rating mean for JNJ?

What factors influence JNJ's Stock IQ?

Explore our JNJ Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored JNJ Stock Strategies
Effective Risk Management

FIND US ON

Receive our JNJ Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

JNJ

Johnson & Johnson

Current Price

$194.39

+$0.50 | +0.26%

52W High

$ 195.55

MKT CAP

$ 468.34B

52W Low

$ 140.68

VOL

$ 5.71M

P/E Ratio

18.76

AVG VOL

$ 8.05M

RSI

66.78

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

JNJ Rewards

Earnings are forecast to grow

JNJ Rewards

Upgraded on attractively valued

JNJ Rewards

Investors confidence is positive

JNJ Rewards

Pays a reliable dividend

Linked to JNJ

Symbol

IQ

Close

Change

NBTX

2.50

21.58

+3.13%

SNDX

3.72

16.79

-5.30%

REGN

4.23

681.72

+1.06%

PFE

3.88

25.84

+1.43%

PCRX

3.59

23.86

-1.08%

JNJ Stock IQ

Login to unlock Johnson & Johnson (JNJ) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$190.9 (+1.83%)

$176.64 (+10.05%)

$150.73 (+28.97%)

$155.5 (+25.01%)

1year

6month

3month

1month

JNJ Analysts Opinion

JNJ Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

JNJ Analysts Opinion

JNJ Analysts opinion is negative and it remained unchanged from the past 3 months

JNJ Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

92%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

80%

JNJ Street Sentiment

JNJ Street Sentiment is extremely bullish and have positive views on the near-term outlook

JNJ Risk Level

JNJ has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

JNJ Performance Sentiment

Sentiments overview associated with JNJ events and the stock performance.

92%

8%

Positive

Negative

33 out of 36
events present

3 out of 36
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$186.97

Resistance
Price

$182.74

Current Price Range

$193.72

Show methods +

JNJ Latest Analysis

Notable Wednesday Option Activity: AMGN SD JNJ. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Amgen Inc (Symbol: AMGN) where a total volume of 12744 contracts has been traded thus far today a contract volume which is representative of approximately 1.3

Today

$194.39 | +0.26%

Momentum

J&Js MedTech Unit Sales Improve: Will the Momentum Last?. J&Js MedTech sales rose 5.6% in Q3 fueled by cardiovascular strength and strategic portfolio shifts toward high-growth markets.

Today

$194.39 | +0.26%

Activity

Dow Analyst Moves: JNJ. The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average Johnson &. Johnson is the #13 analyst pick. Johnson &. Johnson also comes in above the median of analyst picks among the broader

Tue Nov 11, 2025

$193.83 | +2.98%

Potential

Johnson & Johnson (JNJ) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript.

Tue Nov 11, 2025

$193.83 | +2.98%

Activity

Johnson & Johnson (JNJ) Presents at UBS Global Healthcare Conference 2025 Transcript.

Tue Nov 11, 2025

$193.83 | +2.98%

Activity

Wall Street Analysts See Johnson & Johnson (JNJ) as a Buy: Should You Invest?. The average brokerage recommendation (ABR) for Johnson & Johnson (JNJ) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So is it worth buying the stock?

Tue Nov 11, 2025

$193.83 | +2.98%

Potential

Johnson & Johnson: 2 Recent FDA Wins And Earnings Beat Warrant Buy Rating.

Mon Nov 10, 2025

$188.41 | +0.99%

Earnings

Rating

FDA Clears Johnson & Johnsons Darzalex Faspro Enabling Early Intervention In Myeloma Progression. The United States Food and Drug Administration (FDA) approved on Thursday ) Darzalex Faspro (daratumumab and hyaluronidase-fihj) for a .Darzalex Faspro is the first and only approved treatment for high-risk smoldering multiple myeloma (HR-SMM) enabling earlier intervention before the disease progresses to active multiple myeloma.Smoldering multiple myeloma is an asymptomatic (no signs or symptoms) .

Fri Nov 7, 2025

$186.57 | -0.21%

Activity

Potential

Halozyme JNJ Win FDA Approval For DARZALEX Faspro In High-Risk Smoldering Multiple Myeloma . (RTTNews) - Halozyme Therapeutics Inc. (HALO) Friday announced that Johnson & Johnson has received United States Food and Drug Administration approval of a new indication for DARZALEX Faspro as a single agent treatment of adult patients with high-risk smoldering multiple myeloma.

Fri Nov 7, 2025

$186.57 | -0.21%

Activity

Potential

FDA Approves J&J Caplyta As Add-On Therapy For Major Depressive Disorder In Adults . (RTTNews) - Johnson & Johnson (JNJ) on Thursday announced that the United States Food and Drug Administration (FDA) has approved Caplyta as an add-on therapy with antidepressants for the treatment of major depressive disorder (MDD) in adults.

Thu Nov 6, 2025

$186.97 | +0.51%

Activity

Discover JNJ Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of JNJ. We're here to help you make informed investment decisions today.

FIND US ON

Receive our JNJ Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

JNJ Stock trends

JNJ Stock performance

JNJ Stock analysis

JNJ investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing JNJ

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing JNJ

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

JNJ Stock Analysis & IQ Rating | Johnson & Johnson

JNJ Stock IQ

JNJ Target Price

JNJ Risk Level

JNJ Analysts Opinion

JNJ Street Sentiment

JNJ Performance Sentiment

Technical Price Levels

Explore our JNJ Stock insights

Receive our JNJ Daily Alerts

JNJ Stock IQ

JNJ Street Sentiment

JNJ Risk Level

Technical Price Levels

Discover JNJ Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of JNJ. We're here to help you make informed investment decisions today.

Receive our JNJ Daily Alerts

JNJ Runner Alarm